Emerging Diseases News

Globally, cases of malaria in 2022 surpassed the level recorded the year before the start of the COVID-19 pandemic, WHO reported this week.

Nearly half of infectious diseases fellowship programs were not filled on Match Day as the number of applicants declined despite an increase in certified ID programs, the Infectious Diseases Society of America announced.

A recent analysis of global conversations involving almost 1,500 health care professionals on social media from Oct. 1 to 31 has revealed a predominantly positive reaction to the FDA’s approval of Novavax’s updated COVID-19 vaccine.

Moxidectin was noninferior to ivermectin for patients with strongyloidiasis, according to data published in The Lancet Infectious Diseases.

Clinicians and microbiologists who care for patients with diabetic foot infections may be able to decrease the use of mycobacterial cultures and health care costs because these infections are uncommon, according to study data.

We caught up with Mary Foote, MD, MPH, at IDWeek to ask how she got “Hooked on ID.”

Prior infections with chlamydia and/or gonorrhea were common among people diagnosed with mpox, according to data gathered and assessed by the Chicago Department of Public Health.

A novel MRI technique showed brain microstructure changes in people who have had COVID-19, and it traced long COVID symptoms to specific networks of the brain, according to a study.

NEW YORK — In this video, Timothy R. Shope, MD, MPH, reviews COVID-19, influenza and respiratory syncytial virus for general pediatricians in outpatient clinics.

Study findings from hospitals in Copenhagen add to growing data that shorter antibiotic treatment duration is effective for patients with gram-negative bacteremia.